• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌病理中癌基因产物免疫组织化学(c-erbB-2、c-myc、ras p21、表皮生长因子受体)的初步研究

Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.

作者信息

Saccani Jotti G, Fontanesi M, Bombardieri E, Gabrielli M, Veronesi P, Bianchi M, Becchi G, Bogni A, Tardini A

机构信息

Institute of Pathology, University of Parma, School of Medicine, Italy.

出版信息

Int J Biol Markers. 1992 Jan-Mar;7(1):35-42.

PMID:1349907
Abstract

The expression of oncogene products related to cell growth (c-erbB-2, c-myc, ras p21, EGFR) was investigated in benign (15 cases) and malignant breast lesions (20 cases) by means of immunohistochemistry using the avidin-biotin-peroxidase technique with polyclonal and monoclonal antibodies. The aim of this study was to evaluate the relationship between the staining positivity and various morphological and biological features, such as tumour type, grading, hormone receptor status and cell kinetic parameters. In benign breast lesions, as expected, the kinetic parameters were low, both for Ki-67 and LI. All the specimens showed a diploid condition (the DI being equal to 1) and we found a limited degree of immunoreactivity for all the growth factors and oncogene products. In breast cancer we studied the distribution of immunohistochemical positivity for EGFR, c-erbB-2, c-myc, ras p21 and Ki-67, which was related to age, nodal status, ER and PgR receptor status, LI, DI and histopathological grading. A significant positive correlation was found both between ras p21 expression and nodal status and ER-ICA positivity. We observed a strong correlation between LI and Ki-67 and an inverse relation between Ki-67 and ER expression. These findings suggest the importance of studying the relationship between prognostic factors which may provide preoperative prediction in the biological behaviour of breast cancer, not only on biopsy specimens, but also on fine needle aspirates.

摘要

采用抗生物素蛋白-生物素-过氧化物酶技术,使用多克隆和单克隆抗体,通过免疫组织化学方法研究了15例良性和20例恶性乳腺病变中与细胞生长相关的癌基因产物(c-erbB-2、c-myc、ras p21、表皮生长因子受体)的表达情况。本研究的目的是评估染色阳性与各种形态学和生物学特征之间的关系,如肿瘤类型、分级、激素受体状态和细胞动力学参数。正如预期的那样,在良性乳腺病变中,Ki-67和LI的动力学参数均较低。所有标本均显示二倍体状态(DNA指数等于1),并且我们发现所有生长因子和癌基因产物的免疫反应性程度有限。在乳腺癌中,我们研究了表皮生长因子受体、c-erbB-2、c-myc、ras p21和Ki-67免疫组化阳性的分布情况,其与年龄、淋巴结状态、雌激素受体和孕激素受体状态、LI、DNA指数和组织病理学分级有关。在ras p21表达与淋巴结状态和雌激素受体免疫细胞化学阳性之间均发现显著的正相关。我们观察到LI和Ki-67之间有很强的相关性,以及Ki-67与雌激素受体表达之间呈负相关。这些发现表明,研究预后因素之间的关系很重要,这不仅可以在活检标本上,也可以在细针穿刺抽吸物上对乳腺癌的生物学行为进行术前预测。

相似文献

1
Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.乳腺癌病理中癌基因产物免疫组织化学(c-erbB-2、c-myc、ras p21、表皮生长因子受体)的初步研究
Int J Biol Markers. 1992 Jan-Mar;7(1):35-42.
2
Comparison of EGFR, c-erbB-2 product and ras p21 immunohistochemistry as prognostic markers in primary breast cancer.原发性乳腺癌中EGFR、c-erbB-2产物和ras p21免疫组化作为预后标志物的比较。
Eur J Surg Oncol. 1991 Feb;17(1):9-15.
3
Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.关于原癌基因产物(c-erbB-2、表皮生长因子受体、c-myc)及雌激素受体在乳腺良恶性病变中的免疫组织化学研究。特别提及它们在乳腺癌中的预后意义。
Virchows Arch A Pathol Anat Histopathol. 1989;416(1):65-73. doi: 10.1007/BF01606471.
4
p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.乳腺癌中p53和c-erbB-2蛋白表达。一项免疫组织化学研究,包括与人类乳腺癌受体状态、增殖标志物及临床分期的相关性。
Am J Clin Pathol. 1992 Oct;98(4):408-18. doi: 10.1093/ajcp/98.4.408.
5
Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.乳腺癌中癌基因产物ras p21、c-myc及生长因子EGF的免疫组织化学研究
Anticancer Res. 1991 Jul-Aug;11(4):1485-94.
6
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.拓扑异构酶 II alpha 表达和 Ki-67 标记指数与雌激素受体阳性和人表皮生长因子受体 2 阴性乳腺癌的预后因素相关。
Breast Cancer. 2012 Oct;19(4):309-14. doi: 10.1007/s12282-011-0291-4. Epub 2011 Jul 2.
7
ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.人类乳腺癌中的ras、c-myc和c-erbB-2癌蛋白
Anticancer Res. 1989 Sep-Oct;9(5):1385-93.
8
Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer.细胞周期调节因子(p53、p21、pRb和mdm2)及c-erbB-2与乳腺癌增殖生物学标志物和总生存率的相关性
Pathology. 2005 Feb;37(1):45-50. doi: 10.1080/00313020400011250.
9
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.高Ki-67表达和低孕激素受体表达可独立导致雌激素受体阳性且人表皮生长因子受体2阴性的绝经后乳腺癌患者预后较差。
Clin Breast Cancer. 2015 Jun;15(3):204-11. doi: 10.1016/j.clbc.2014.12.007. Epub 2014 Dec 24.
10
Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.免疫组织化学检测人乳腺良恶性病变中转化生长因子-α、表皮生长因子受体、c-erbB-2、c-H-ras、c-myc、雌激素和孕激素:伴随表达
In Vivo. 1994 Mar-Apr;8(2):183-9.

引用本文的文献

1
ZFHX3 Promotes the Proliferation and Tumor Growth of ER-Positive Breast Cancer Cells Likely by Enhancing Stem-Like Features and and Transcription.锌指同源盒蛋白3可能通过增强类干细胞特性和转录促进雌激素受体阳性乳腺癌细胞的增殖和肿瘤生长。
Cancers (Basel). 2020 Nov 18;12(11):3415. doi: 10.3390/cancers12113415.
2
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.c-MYC 蛋白表达对接受曲妥珠单抗辅助治疗的早期 HER2+乳腺癌患者结局的影响:NCCTG(联盟)N9831 研究
Clin Cancer Res. 2013 Oct 15;19(20):5798-807. doi: 10.1158/1078-0432.CCR-13-0558. Epub 2013 Aug 21.
3
High corn oil and extra virgin olive oil diets and experimental mammary carcinogenesis: clinicopathological and immunohistochemical p21Ha-Ras expression study.
高玉米油和特级初榨橄榄油饮食与实验性乳腺癌发生:临床病理和免疫组化 p21Ha-Ras 表达研究。
Virchows Arch. 2011 Feb;458(2):141-51. doi: 10.1007/s00428-010-1036-z. Epub 2011 Jan 15.
4
Clinical value of enzyme immunoassay of epidermal growth factor receptor in human breast cancer.
Breast Cancer Res Treat. 1993 Dec;28(3):215-21. doi: 10.1007/BF00666582.